Reversing Vecuronium Induced Neuromuscular Blockade In Patients Undergoing General Anesthesia Surgery

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Reversing Vecuronium Induced Neuromuscular Blockade In Patients Undergoing General Anesthesia Surgery trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT07595393

A Dose-Finding Study of Amogammadex Sodium for Reversing Vecuronium and Rocuronium-Induced Neuromuscular Blockade

Background context: Amogammadex sodium has completed Phase I-III clinical studies in China for reversal of rocuronium-induced blockade. No clinical studies have…

Location not specified64 participantsStarted 2026-08-01Updated 2026-05-19

Treatment: Rocuronium (0.6mg/kg), vecuronium bromide (0.1mg/kg)